| Active Ingridient | Ciprofloxacin and Ornidazole |
| Brand | Ciproplit O |
| Country of origin | India |
| Form | Oral Tablet |
Ciproplit O Tablet is combined with the active compounds Ciprofloxacin and Ornidazole. It is used for treating mixed bacterial and parasitic infections. This medicine helps in controlling infection-causing organisms and supports faster recovery. To get the best result, take this medicine always exactly at the same time as prescribed by your doctor.
Clinical Uses
Ciproplit O Tablet is used to treat bacterial infections, diarrhea, vaginal bacterial or protozoal infections, gynaecological, and pelvic infections. It is also helpful for mixed teeth or gum infections.
Dose Options
There are two dose strengths of Ciproplit O Tablet available: 250 mg and 500 mg. The right dose is decided by the doctor depending on the type and severity of your condition.
How It Works
Ciprofloxacin and Ornidazole are two antibacterial agents in Ciproplit O Tablet. Ciprofloxacin works as a fluoroquinolone antibiotic that blocks the enzymes DNA gyrase and topoisomerase IV. These enzymes are essential for bacterial DNA replication and cell division. By blocking these enzymes, Ciprofloxacin destroys bacterial cells and kills the bacteria. Ornidazole is a nitroimidazole antibiotic that kills parasites and anaerobic bacteria that cause infections by damaging their DNA. Together, Ciprofloxacin and Ornidazole treat infections effectively.
Side Effects
Possible side effects of Ciproplit O Tablet are:
- Nausea
- Vomiting
- Headache
- Abdominal pain
- Diarrhea
- Dizziness
- Loss of appetite
- Metallic taste or bitter taste
Some serious side effects that need medical attention include:
- Severe allergic reactions such as rash, hives, swelling
- Difficulty breathing
- Seizures
- Liver function abnormalities
- Joint stiffness or tenderness
Precautions & Warnings
- Avoid drinking alcohol while taking Ciproplit O Tablet, or do not drink for at least 48 hours after the last dose.
- Ciproplit O Tablet can cause dizziness or lightheadedness, so do not drive or operate heavy machinery while taking the medication.
- This medication is generally not prescribed to pregnant and breastfeeding women. However, the doctor may consult you about taking this medicine during these periods.
- Patients with kidney or liver disease should use this medicine with caution.
- Finish the full course of the medication even if the symptoms go away. Stopping the medication suddenly can lead to incomplete treatment and antibiotic resistance.
Drug Interactions
Ciproplit O Tablet can interact with the following medicines:
- Blood thinners such as Warfarin.
- Antacids and vitamins such as magnesium hydroxide, aluminum hydroxide, iron, or zinc.
- Heart rhythm medicines such as quinidine and amiodarone.
- Asthma medicines like theophylline.
Disclaimer
At 5M Biotech India we provide accurate, reliable and expert reviewed information. However, all our content on this platform is intended for informational purposes only and is not professional medical advice, diagnosis or treatment. While we make efforts to maintain accuracy, the information may contain mistakes, omissions or may not reflect the latest developments. Always consult your doctor regarding any medical concerns.
All medicine names, trademarks, and registered trademarks displayed on 5M Biotech India are property of their respective owners. 5M Biotech India and its operator are not affiliated with, endorsed by or authorized by any such trademark owners unless stated expressly. Any reference to trademarks or product names is made for informational purposes. No sponsorship, commercial relationship, approval or association with any trademark owner should be inferred. Information provided herein does not constitute advertising, promotion or an offer for sale of any medicinal goods and is intended solely for general informational purposes.
All trademarks, trade names, and brand names displayed on this website are used strictly in accordance with the applicable provisions of the Trade Marks Act, 1999, including Sections 30 and 30(1) relating to permitted and fair use. The respective trademark ownership has been duly and accurately identified under the “Manufacturer/TM Owner” section in compliance with applicable statutory requirements.
